Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03989947
Recruitment Status : Enrolling by invitation
First Posted : June 18, 2019
Last Update Posted : June 29, 2021
Information provided by (Responsible Party):
BioMarin Pharmaceutical

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : September 2026
Estimated Study Completion Date : December 2026